---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-011978"
form_type: "8-K"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2022-06-23T23:59:59+00:00"
generated_at: "2026-06-24T23:35:56.264175+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Eledon Pharmaceuticals annual meeting elects directors and ratifies auditor

## Summary
- Stockholders elected Keith A. Katkin (7,330,714 for, 765,231 withhold) and John S. McBride (7,287,222 for, 808,723 withhold) as Class II directors for term ending 2025.
- Ratified KMJ Korbin & Company LLP as independent auditor for FY2022 with 10,173,336 for, 10,380 against, 3,433 abstain.
- All proposals passed at the June 21, 2022 annual meeting.

## SEC filing metadata
- accession: 0000950170-22-011978
- form_type: 8-K
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2022-06-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000095017022011978/0000950170-22-011978-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000095017022011978/eldn-20220622.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-011978
- JSON: https://secwatch.observer/filing/0000950170-22-011978.json
- Plain text: https://secwatch.observer/filing/0000950170-22-011978.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.